Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Phase Genomics logo — Blueprints for Biology™: Hi-C Genomics, Metagenomics, and Ep...

Phase Genomics

Blueprints for Biology™: Hi-C Genomics, Metagenomics, and Epigenomics

Founded 2015 United States Seattle, United States 13 employees Total: $22.59M Biotechnology, Clean Energy

General Information

Company Name Phase Genomics
Founded Year 2015
Location United States Seattle, United States
Founders / Decision Makers
Team member Team member
Employees 13
Industries Biotechnology, Clean Energy
Business Model B2B, Platform, SaaS
Revenue Model Product Sales, Service Fee, Subscription
Social

BounceWatch is an independent company data service, not affiliated with Phase Genomics. To contact Phase Genomics, visit phasegenomics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Phase Genomics compare?

A PDF of Phase Genomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Phase Genomics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Phase Genomics

Phase Genomics, founded in 2015, is a pioneering company in the Biotechnology and Clean Energy sectors, headquartered in the United States. The company is renowned for its tagline, "Blueprints for Biology™: Hi-C Genomics, Metagenomics, and Epigenomics", which encapsulates its commitment to advancing the field through innovative genomic analysis techniques.

Utilizing cutting-edge Hi-C and proximity-ligation technologies, Phase Genomics specializes in chromosome-scale genome assembly and metagenomic deconvolution. It offers a broad range of sophisticated laboratory and computational solutions, including Hi-C kits tailored for various biological samples and leading-edge genome assembly software. This enables its clients, both in academic and commercial domains, to undertake comprehensive structural genomic analyses.

The company's recent financing—a $1.50M grant from the Bill & Melinda Gates Foundation on 04 March 2024—attests to its strategic importance and potential for impact in the realms of scientific research and innovation.

Business keywords: Genomics, Hi-C, Metagenomics, Bioinformatics, Genome Assembly, Microbiome, Scientific Research, Agriculture, Human Health, Industrial Biology, NGS (Next-Generation Sequencing), Diagnostic, DNA Sequencing, Cancer

Services & Products

Ultra-long-range Sequencing Technology
Proximity Genome Mapping
Computational Platforms for Genomic Analysis
Chromosome-scale Reference Genome Construction

Target Customers

Academic Research Organizations Biopharmaceutical Companies Biotechnology Institutes Scientists in Life Sciences and Medicine

Funding Rounds & Investors (11)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $1.50M 1
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
01 Mar 2024
Grant $2.50M 2
Andy Hill Cancer Research Endowment (CARE) Fund
Andy Hill Cancer Research Endowment (CARE) Fund, National Cancer Institute (NCI)
01 Aug 2023
Early VC $3.29M -
01 Apr 2023
Grant $5.50M 2
Bill & Melinda Gates Foundation National Investment Co.
Bill & Melinda Gates Foundation, National Investment Co.
01 Jun 2022
Grant $1.70M 1
National Investment Co.
National Investment Co.
01 Feb 2021
Grant $3.90M 1
National Institute of Health
National Institute of Health
01 Sep 2020
Grant $1.50M 1
National Investment Co.
National Investment Co.
01 Jan 2020
Grant $200.00K 1
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
01 Feb 2019
Grant $1.50M 1
National Institute of Health
National Institute of Health
01 Jun 2018
Seed $1.00M 1
Congruent Ventures
Congruent Ventures
01 Dec 2017

View All 11 Funding Rounds

Phase Genomics Alternatives & Competitors

View All Alternatives
Phase Genomics vs
Macrogen Europe
Macrogen Europe The Netherlands

Committed to Sequencing Excellence

71 employees
Biotechnology, Health Care
Phase Genomics vs
SciGenom Labs
SciGenom Labs United States

Leveraging science of the genome.

18 employees
Biotechnology, Health Care
Phase Genomics vs
Novogene Europe
Novogene Europe United Kingdom

Leading Edge Genomic Services & Solutions

Series B
147 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About Phase Genomics

Blueprints for Biology™: Hi-C Genomics, Metagenomics, and Epigenomics
Phase Genomics was founded in 2015.
Phase Genomics is headquartered in Seattle, United States.
Phase Genomics operates in Biotechnology and Clean Energy. Its work centres on Genomics, Hi-C, Metagenomics and Bioinformatics. Its customers include Academic Research Organizations, Biopharmaceutical Companies and Biotechnology Institutes.
Phase Genomics has a B2B, Platform and SaaS business model. Its revenue comes from Product Sales, Service Fee and Subscription.
Phase Genomics has approximately 13 employees.
Phase Genomics has completed 11 funding rounds, raising a total of $22.59M.
Phase Genomics offers: Ultra-long-range Sequencing Technology, Proximity Genome Mapping, Computational Platforms for Genomic Analysis, Chromosome-scale Reference Genome Construction.
Top alternatives and competitors to Phase Genomics include Macrogen Europe, SciGenom Labs, Novogene Europe, Personal Genome Diagnostics, Salus Biomed 赛陆医疗. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Phase Genomics and Macrogen Europe are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Phase Genomics, https://bouncewatch.com/company/phase-genomics, updated 20 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes